ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,952Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 1006

$989K Total Retail Price of All Prescriptions

Rank: 40 out of 1006

510 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,935 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 401 356 1 8
SIMVASTATIN 387 361 2 1
FUROSEMIDE 378 334 3 6
LISINOPRIL 367 306 4 3
METOPROLOL TARTRATE 266 250 5 7
METFORMIN HCL 261 214 6 10
OMEPRAZOLE 221 188 7 9
AMLODIPINE BESYLATE 216 202 8 4
HYDROCHLOROTHIAZIDE 211 190 9 11
OXYCODONE HCL 205 153 S2 10 54
POTASSIUM CHLORIDE 192 160 11 30
DIOVAN 182 164 12 16
ATORVASTATIN CALCIUM 178 169 13 5
LEVOTHYROXINE SODIUM 164 134 14 2
DONEPEZIL HCL 158 158 15 17
PANTOPRAZOLE SODIUM 157 120 16 32
JANUVIA 155 146 17 49
GABAPENTIN 154 138 18 20
METOPROLOL SUCCINATE 149 123 19 12
TAMSULOSIN HCL 139 123 20 23
TRAZODONE HCL 136 110 21 21
CITALOPRAM HBR 123 102 22 24
BUDESONIDE 120 108 23 245
ATENOLOL 118 112 24 13
KLOR-CON M20 116 84 25 70
BENAZEPRIL HCL 113 98 26 112
LANTUS 105 101 27 43
QUETIAPINE FUMARATE 101 99 28 45
CARVEDILOL 91 77 29 36
ZOLPIDEM TARTRATE 90 72 30 14
CYMBALTA 89 73 31 41
ALLOPURINOL 85 76 32 31
CLOPIDOGREL 84 70 33 46
LOSARTAN POTASSIUM 79 66 34 22
SPIRIVA 79 62 34 48
PREDNISONE 77 73 36 33
AMITRIPTYLINE HCL 74 49 R 37 150
MIRTAZAPINE 73 70 38 26
LABETALOL HCL 73 73 38 164
FLUTICASONE PROPIONATE 72 47 40 55
ADVAIR DISKUS 72 37 40 37
ZETIA 71 40 42 51
OXYCONTIN 71 33 S2 42 98
PAROXETINE HCL 69 57 44 62
FLUOXETINE HCL 68 36 45 85
DIVALPROEX SODIUM 68 61 45 53
PRAVASTATIN SODIUM 67 50 47 15
NOVOLOG 66 61 48 94
RISPERIDONE 64 53 49 40
SERTRALINE HCL 63 62 50 19
CHLORHEXIDINE GLUCONATE 63 18 50 136
CYCLOBENZAPRINE HCL 62 33 R 52 113
FINASTERIDE 60 60 53 76
NEXIUM 60 39 53 28
SPIRONOLACTONE 59 42 55 71
ALENDRONATE SODIUM 58 47 56 29
OXYBUTYNIN CHLORIDE ER 58 38 56 92
HYDROCODONE-ACETAMINOPHEN 57 45 S3 58 25
LOVASTATIN 57 57 58 44
ESCITALOPRAM OXALATE 57 56 58 27
ACTOS 56 55 61 89
ALBUTEROL SULFATE 56 48 61 155
PLAVIX 56 51 61 61
CARAFATE 53 45 64 275
IPRATROPIUM-ALBUTEROL 53 50 64 73
DIOVAN HCT 53 47 64 60
CRESTOR 52 50 67 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.